Egypt Presents Its Vision for Developing the Pharmaceutical Sector Until 2030 at an International Medical Conference
The Chairman of the Egyptian Drug Authority (EDA) participated in the fifth edition of the Africa Health ExCon 2026. During this significant event, Egyptian officials showcased the most prominent achievements of the country's pharmaceutical sector, in addition to presenting comprehensive development plans aimed at reaching ambitious goals by 2030.
The Chairman explained that Egypt has achieved great success in securing the local market's needs for essential medicines. He also noted that the Authority is working diligently to implement the highest international manufacturing standards, which has helped improve the quality of Egyptian products and open new export markets, particularly within the African continent.
Egypt's Vision 2030 includes a focus on localizing the advanced pharmaceutical industry and scientific research. These plans aim to reduce reliance on imports, provide the latest treatments to Egyptian citizens at affordable prices, and contribute to supporting the national economy and improving living standards.
The conference also emphasized the importance of joint cooperation among African countries in the fields of health and medicine. The medical exhibition seeks to provide a platform for exchanging expertise and attracting foreign investments to Egypt, reinforcing Cairo's position as a leading regional hub for healthcare and the pharmaceutical industry.
In conclusion, these efforts reflect the Egyptian state's commitment to developing the health system and protecting citizens' health. Investing in the pharmaceutical sector is an essential step toward achieving self-sufficiency and ensuring a healthy and secure future for all Egyptians.